CHARLES RIVER LABORATORIES INTERNATIONAL, INC. acquires MPI Research
Snapshot
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. acquired MPI Research for approximately $800 million in cash in April 2018. The transaction was structured as all cash. MPI Research is a United States (Mattawan, Michigan)-based Discovery and Safety Assessment (DSA) business.
- Acquirer
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Target
- MPI Research
- Value
- approximately $800 million in cash
- Date
- April 2018
- Type
- full acquisition
- Status
- ready
The deal at a glance
About this deal
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. acquired MPI Research for approximately $800 million in cash, a transaction completed in April 2018, structured as all cash.
MPI Research operates in Discovery and Safety Assessment (DSA), is based in United States (Mattawan, Michigan). MPI Research was a premier non-clinical contract research organization providing safety assessment, discovery, and bioanalytical services, with a large site in Mattawan, Michigan.
Acquiring MPI will enhance Charles River's position as a leading global early-stage CRO by strengthening its ability to partner with clients across the drug discovery and development continuum.
Access to growing end markets, high-quality services, scientific expertise, and complementary capabilities Expected non-GAAP EPS accretion of approximately $0.25 in 2018 and approximately $0.60 in 2019 Discovery and Safety Assessment (DSA) segment
No advisory firms have been disclosed for this transaction.